{"name":"OncoPep, Inc.","slug":"oncopep-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPNTgxekI3S1BoSWJnZWc3Uk9kdHdGTi02UHNKM3VxY2xKVmIzSUxnMUh2VFg4QUN1akZCTFhhdGl4SFgxTFVIckNJWmxpNGxUWExBTEt3OWpOWW40cUJlcDBia2NkUUh6bmxrUzRMbDYxWVR3LU9PYU1PY0VwTVBQUU82WGd1NDFVeHhUZ2NpWFBTSW9RNWFJYUU0ZkVpY2l4SHViUGpMdVY0Wk5XVEZ6dzltVVdNMFdKaUt6bUJCbDFtWUhUaE90U3RsMTBCMnp2UlIxNWpfWVdHYjlMQVdVYU9uandva1UxS0d1WWVuR3doaS1RWXc?oc=5","date":"2024-07-15","type":"trial","source":"European Medical Journal","summary":"What Does the Phase III ‘IMROZ’ Study Mean for Patients with Multiple Myeloma? An Interview with the Co-authors - European Medical Journal","headline":"What Does the Phase III ‘IMROZ’ Study Mean for Patients with Multiple Myeloma? An Interview with the Co-authors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOMGJHY0tueFFDaU4yX1lrYkxKRkxyMzFfYTNNYmF6dmUzU3BYb2tsZnFsTW54S0VyZENjOVVmM3h5Y0l0X2owU0daVVdOSVhhWWZTMVg1bDJFbHE4ZHVLY1ZROWJCcmlEZjZXWWhkRnVHaDlUSFloZFNsM09wQW9OZUNPSUR1SmVmRHc?oc=5","date":"2023-11-28","type":"pipeline","source":"Yahoo Finance","summary":"Triple-Negative Breast Cancer Market to Grow Rapidly During the Forecast Period (2023–2032), Predicts DelveInsight | Key Companies in the Market - AstraZeneca, Daiichi Sankyo, Pfizer, OncoSec, Merck, ","headline":"Triple-Negative Breast Cancer Market to Grow Rapidly During the Forecast Period (2023–2032), Predicts DelveInsight | Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxORW1wZVB0SlVJNjE3NUs4bEtoR2JpOTRQUlBOZHQxdG5jS3Q2NERQeHRzeGdhTl9wZjhtODJaYnBXTjM5QlhndFIwNTFmeTYxMWpzeWVQM08tSXRfZFNzaEFNVEJjQTRya2h1OHI5M3ZUVFdsdFhYOHFGUXBVYk1FWEdUTTVmbERWTjRON0F2TTVjWFoyVlNheGtPRm5nYUE?oc=5","date":"2022-05-17","type":"pipeline","source":"citybiz","summary":"Dr. Victor Moyo, MBChB, Joins OncoPep as Chief Medical Officer - citybiz","headline":"Dr. Victor Moyo, MBChB, Joins OncoPep as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}